Ablacon
Cortex develops the OptiMap System, an AI-powered, 510(k) cleared electrographic flow mapping solution for diagnosing and treating atrial fibrillation (AF). The system uses a 64-electrode basket catheter and an innovative optical flow algorithm to visualize and reconstruct the chaotic electrical conduction in AF, enabling personalized treatment by identifying active AF sources beyond pulmonary veins. Cortex's technology aims to improve ablation outcomes by facilitating focused, minimal ablation strategies tailored to individual patient pathophysiology. The company combines clinical, technical, and scientific expertise with a strong advisory board and has published extensive research validating its technology's efficacy and reproducibility in complex AF cases.
Ablacon
Cortex develops the OptiMap System, an AI-powered, 510(k) cleared electrographic flow mapping solution for diagnosing and treating atrial fibrillation (AF). The system uses a 64-electrode basket catheter and an innovative optical flow algorithm to visualize and reconstruct the chaotic electrical conduction in AF, enabling personalized treatment by identifying active AF sources beyond pulmonary veins. Cortex's technology aims to improve ablation outcomes by facilitating focused, minimal ablation strategies tailored to individual patient pathophysiology. The company combines clinical, technical, and scientific expertise with a strong advisory board and has published extensive research validating its technology's efficacy and reproducibility in complex AF cases.